Literature DB >> 3005298

Purification and characterization of the human brain insulin receptor.

R A Roth, D O Morgan, J Beaudoin, V Sara.   

Abstract

The insulin receptor from human brain cortex was purified by a combination monoclonal antibody affinity column and a wheat germ agglutinin column. This purified receptor preparation exhibited major protein bands of apparent Mr = 135,000 and 95,000, molecular weights comparable to those for the alpha and beta subunits of the purified human placental and rat liver receptors. A minor protein band of apparent Mr = 120,000 was also observed in the brain receptor preparation. Crosslinking of 125I-insulin to all three receptor preparations was found to preferentially label a protein of apparent Mr = 135,000. In contrast, cross-linking of 125I-labeled insulin-like growth factor I to the brain preparation preferentially labeled the protein of apparent Mr = 120,000. The purified brain insulin receptor was found to be identical with the placental insulin receptor in the amount of neuraminidase-sensitive sialic acid and reaction with three monoclonal antibodies to the beta subunit of the placental receptor. In contrast, a monoclonal antibody to the insulin binding site recognized the placental receptor approximately 300 times better than the brain receptor. These results indicate that the brain insulin receptor differs from the receptor in other tissues and suggests that this difference is not simply due to the amount of sialic acid on the receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Localization and synthesis of an insulin-binding region on human insulin receptor.

Authors:  S Nakamura; S Sakata; M Z Atassi
Journal:  J Protein Chem       Date:  1990-04

Review 2.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

3.  Ontogenesis of insulin receptors in human cerebral cortex.

Authors:  N Potau; M A Escofet; M C Martinez
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

4.  Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens.

Authors:  T Hansen; J Stagsted; L Pedersen; R A Roth; A Goldstein; L Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Insulin and insulinlike growth factor 1 (IGF-1) receptors during central nervous system development: expression of two immunologically distinct IGF-1 receptor beta subunits.

Authors:  R S Garofalo; O M Rosen
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

6.  Expression and purification of functional insulin and insulin-like growth factor 1 holoreceptors from mammalian cells.

Authors:  Richard J Delle Bovi; W Todd Miller
Journal:  Anal Biochem       Date:  2017-08-19       Impact factor: 3.365

7.  Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein.

Authors:  G Sesti; A N Tullio; R D'Alfonso; M L Napolitano; M A Marini; P Borboni; R Longhi; L Albonici; A Fusco; A M Aglianò
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

8.  Purification and characterization of a Mn2+/phospholipid-dependent protein phosphatase from pig brain membranes.

Authors:  J S Yu; S D Yang
Journal:  J Protein Chem       Date:  1989-08

9.  A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors.

Authors:  R H Ganderton; K K Stanley; C E Field; M P Coghlan; M A Soos; K Siddle
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

10.  Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.

Authors:  I Moroo; T Yamada; H Makino; I Tooyama; P L McGeer; E G McGeer; K Hirayama
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.